MYOCARDIAL FIBROSIS ATTENUATES THE EFFECT OF CIBENZOLINE ON LEFT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY  by Saito, Makoto et al.
A23.E217
JACC March 9, 2010
Volume 55, issue 10A
 CARDIAC FUNCTION AND HEART FAILURE 
MYOCARDIAL FIBROSIS ATTENUATES THE EFFECT OF CIBENZOLINE ON LEFT VENTRICULAR DIASTOLIC 
FUNCTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Sunday, March 14, 2010, 3:30 p.m.-4:30 p.m.
Session Title: Cardiomyopathies
Abstract Category: Cardiomyopathies/Myocarditis/Pericardial Disease
Presentation Number: 1067-48
Authors: Makoto Saito, Yasuhiro Sasaki, Toyofumi Yoshii, Go Hiasa, Takumi Sumimoto, Kazuhisa Nishimura, Katsuji Inoue, Hideki Okayama, Mareomi 
Hamada, Jitsuo Higaki, Kitaishikai hospital, Ozu, Japan
Backgrounds: The late gadolinium enhancement (LGE) on contrast-enhanced magnetic resonance imaging (CE-MRI) in hypertrophic cardiomyopathy 
(HCM) has been reported to be associated with myocardial fibrosis. We have previously reported that the class Ia antiarrhythmic drug, cibenzoline 
(CBZ), improves LV diastolic function in patients with HCM. The aim of this study was to investigate whether LGE were associated with the effect of 
CBZ on LV diastolic function in patients with HCM.
Methods: Echocardiographic examination before and after the intravenous administration of CBZ (1.4 mg/kg over 5 min) and CE-MRI was 
performed in 22 consecutive patients with HCM (Mean age: 66±14 years, Obstructive : 14, Non-obstructive : 8). The extent of LGE (%LGE = LGE 
volume/ total LV volume) obtained by CE-MRI using custom software.
Results: LGE were observed in 19 patients (86% : mean %LGE = 5.6%). After administration of CBZ, a significant reduction in LV pressure gradient 
(LVPG) was achieved in patients with obstructive HCM (from 75 ± 40 to 25 ± 24 mm Hg, P < 0.001). Furthermore, propagation velocity (Vp) 
increased significantly in patients with obstructive HCM (from 26 ± 7 to 36 ± 14 cm/s, P = 0.001) and non-obstructive HCM (from 25 ± 9 to 36 ± 
16 cm/s, P = 0.007). A significant A negative correlation was observed between the change rate of Vp and %LGE in patients with obstructive HCM (r 
= -0.582, P = 0.029) and non-obstructive HCM (r = -0.766, P = 0.027).
Conclusion: The extent of myocardial damage demonstrated by LGE on CE-MRI might be associated with the improvement effect of CBZ on LV 
diastolic function in patients with obstructive and non-obstructive HCM.
